Quipt Home Medical (NASDAQ:QIPT) Downgraded to Strong Sell Rating by Stifel Canada

Stifel Canada downgraded shares of Quipt Home Medical (NASDAQ:QIPT) from a strong-buy rating to a strong sell rating in a research note issued to investors on Monday morning,Zacks.com reports.

A number of other equities research analysts also recently commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Quipt Home Medical in a report on Wednesday, October 8th. Benchmark restated a “buy” rating on shares of Quipt Home Medical in a report on Tuesday. Finally, Canaccord Genuity Group raised their target price on Quipt Home Medical from $1.70 to $2.30 and gave the stock a “hold” rating in a research note on Tuesday, August 19th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $3.83.

Quipt Home Medical Trading Down 0.1%

Shares of NASDAQ QIPT traded down $0.01 during mid-day trading on Monday, reaching $3.52. The company had a trading volume of 193,795 shares, compared to its average volume of 554,780. Quipt Home Medical has a 52 week low of $1.35 and a 52 week high of $3.54. The stock has a market cap of $152.71 million, a price-to-earnings ratio of -14.06 and a beta of 0.59. The business’s 50-day moving average is $2.47 and its 200-day moving average is $2.32. The company has a current ratio of 1.15, a quick ratio of 0.75 and a debt-to-equity ratio of 0.71.

Quipt Home Medical (NASDAQ:QIPT) last issued its quarterly earnings data on Monday, December 15th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.11). Quipt Home Medical had a negative return on equity of 10.32% and a negative net margin of 4.38%.The business had revenue of $68.30 million during the quarter, compared to the consensus estimate of $87.46 million. Equities analysts expect that Quipt Home Medical will post -0.05 earnings per share for the current year.

Institutional Investors Weigh In On Quipt Home Medical

A number of large investors have recently modified their holdings of the company. Retirement Planning Co of New England Inc. acquired a new position in shares of Quipt Home Medical during the third quarter worth $26,000. Diversify Advisory Services LLC purchased a new position in shares of Quipt Home Medical in the 2nd quarter valued at about $29,000. Catalyst Funds Management Pty Ltd acquired a new stake in shares of Quipt Home Medical during the 2nd quarter worth about $31,000. Y Intercept Hong Kong Ltd purchased a new stake in Quipt Home Medical during the second quarter worth approximately $34,000. Finally, XTX Topco Ltd acquired a new position in Quipt Home Medical in the second quarter valued at approximately $70,000. 42.85% of the stock is owned by hedge funds and other institutional investors.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.